Dossier
rss
preclinical
Growth Hormone Receptor Antagonism Extends Lifespan
Key claim: Growth hormone receptor antagonism extends lifespan.
Abstract
Aging Cell, Volume 25, Issue 9, September 2026.
Why this matters
The GH/IGF-1 axis is one of the most reproducible longevity levers in mammals, but until now the lifespan evidence came almost entirely from genetic dwarf and GHRKO mouse models. A pharmacological GHR antagonist reproducing that phenotype moves the axis one step closer to a druggable geroprotector class, though the evidence remains preclinical and sits alongside — not above — the existing rapamycin/mTOR and metformin animal data.